To download the latest issue
Feb 6th, 2014
Tasso, Inc., a medtech start-up developing a wearable blood draw device, has secured $2.3M in grant funding for its HemoLink¬™ technology
After a successful SBIR Phase I, the Defense Advanced Research Projects Agency has granted the company an additional $1.75M in a Phase II effort to demonstrate large volume sample acquisition from the capillary bed.
The NIH, National Institute on Minority Health and Health Disparities, has also granted the company a Phase I SBIR of $400k in an effort to provide better health care for underprivileged populations. Professor David Beebe, recently named to the board of directors, comments, "Tasso has generated data that demonstrates a 200 microliter blood draw with a proprietary microfluidic platform. This is a significant achievement in the field of blood sample acquisition and I am excited about its potential for collecting even larger volumes."
More MEDTECH news